Varigate
Varigate is the world's most advanced irrigation software service, delivering dramatic water cost savings and increased crop & dairy yield.
- Stage Full Product Ready
- Industry Clean Technology
- Location Wellington, New Zealand
- Currency NZD
- Founded August 2013
- Employees 7
- Website varigate.co.nz
Company Summary
Varigate is a software service that delivers dramatic cost savings and increased yield to dairy farms, by optimizing irrigation. Deployment is simple, farmer friendly and low maintenance. Scalable delivery through powerful distribution channels. Strong revenues, huge domestic and offshore potential. Earlier technology developed by scientists - acquired by world leader. Strong IP position. Management team with impressive execution track record.
Team
-
Ervin LeiboviciBoard MemberFormer VP at Netafim (market cap $780 million) the world leader in drip irrigation, who managed over half of its revenue-generating operations (North America, Europe, Middle East, Africa, Australia and Japan).
-
Isaac BentwichCEO and ChairmanFounded and led two Israeli technology companies to be world leaders in their respective fields. The first of these, one of Israel’s first medical software success stories, was acquired for $15 million by HBOC (now McKessen, Fortune 14). The second, biotech company Rosetta Genomics (NASDAQ:ROSG), is a world leader in its field. Rosetta’s subsidiary, Rosetta Green (TASE:RSTG) was recently acquired for $35M by Monsanto (NYSE:MON, $55B).
-
Robert LangerBoard MemberNamed by Forbes as one of the 15 innovators worldwide who will reinvent our future, inventor of over 800 patents licensed to over 250 companies, former board member of Wyeth Pharmaceuticals ($68B).
-
Marcel van den AssumBoard MemberFormer CIO of Fonterra ($10B), New Zealand’s largest company responsible for 30% the world’s dairy exports. Held senior information services leadership roles, and governance roles, as supplier and customer, in New Zealand and offshore locations, for commercial and public sector organisations.
-
Aaron CiechanoverChairman, Scientific Advisory BoardNobel Laureate, Chemistry (2004) An anti canter drug based on this discovery is now in development. Member of the Pontifical Academy of Sciences, a group of 80 of the world’s most highly regarded scientists.
Advisors
-
Bruno Bordignon, Duncan CotterillLawyerUnconfirmed
Vijay Kumar Goel, Jolly Duncan & Wells LimitedAccountantUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.